Condition

Breast Reconstruction Surgery clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Breast Reconstruction Surgery clinical trials that are recruiting, at sites in 2 countries (most in United Kingdom (2), United States (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Breast Reconstruction Surgery clinical trials

StudyPhaseWhereStatusRegistered
Partial breast reconstruction using chest wall perforator flaps — Cambridge, Cambridgeshire Recruiting Dec 11, 2024
New device for breast reconstruction after mastectomy — Scottsdale, Arizona and 19 other locations Recruiting Aug 16, 2024
Long-term follow-up of Nagor Perle smooth gel mammary implants — Manchester Recruiting Aug 28, 2023

All recruiting trials (3)

Related topics

Breast AugmentationBreast Cancer Early Stage Breast Cancer (Stage 1-3)Breast CarcinomaBreast NeoplasmsBreast ReconstructionBreast Reconstruction After MastectomyBreast Surgery

Quick answers

How many Breast Reconstruction Surgery clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in United Kingdom (2 trials), United States (1 trial). Each study page lists its sites and which ones are recruiting.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.